The pharmaceutical industry faces unprecedented pressure to bring new drugs to market faster while maintaining the highest standards of quality and safety. Particle size analysis has emerged as one of the most critical analytical techniques in modern drug development, influencing everything from drug bioavailability and dissolution rates to manufacturing consistency and shelf stability. At Malvern Panalytical, our portfolio of particle characterisation instruments enables pharmaceutical scientists to make informed decisions at every stage of the drug development pipeline.
The Critical Role of Particle Size in Drug Formulation
Particle size directly impacts the performance of pharmaceutical formulations. For oral solid dosage forms, smaller particle sizes generally lead to increased surface area, faster dissolution rates, and improved bioavailability. However, excessively fine particles can create handling difficulties, poor flow properties, and stability issues. Finding the optimal particle size distribution is therefore a delicate balancing act that requires precise, reproducible measurement techniques.
Our Mastersizer range, which uses laser diffraction technology, has become the industry standard for particle size analysis in pharmaceutical laboratories worldwide. The instrument measures particle size distributions across a range of 10 nanometres to 3.5 millimetres in a single measurement, providing comprehensive characterisation of active pharmaceutical ingredients, excipients, and finished formulations.
Nanoparticle Characterisation for Advanced Drug Delivery
The rapid growth of nanomedicine has created new demands for particle characterisation below the micrometre scale. Liposomal formulations, polymer nanoparticles, and lipid nanoparticles used in mRNA vaccine delivery all require precise size measurement in the nanometre range. Our Zetasizer platform combines dynamic light scattering with electrophoretic light scattering to deliver simultaneous measurements of particle size, zeta potential, and molecular weight, providing comprehensive characterisation of complex nanoformulations.
Process Analytical Technology and Quality by Design
The pharmaceutical industry's adoption of Quality by Design principles and Process Analytical Technology frameworks has elevated the importance of real-time particle size monitoring during manufacturing. By integrating particle size analysers directly into milling, granulation, and blending processes, manufacturers can detect and correct deviations in real time, reducing batch failures and improving overall product quality.
- Wet milling optimisation β Real-time monitoring ensures target particle size is achieved efficiently
- Granulation endpoint detection β Inline measurement identifies optimal granule size during wet granulation
- Blend uniformity assessment β Particle size distribution confirms homogeneous mixing of API and excipients
- Coating thickness control β Monitoring particle size changes during film coating ensures uniform coverage
Regulatory Compliance and Method Development
Regulatory agencies including the FDA and EMA require robust particle size data as part of drug approval submissions. Our instruments are designed with regulatory compliance in mind, offering full 21 CFR Part 11 compatibility, comprehensive audit trails, and validated measurement methods. Our dedicated pharmaceutical application scientists work closely with customers to develop and validate particle size methods that meet the most stringent regulatory requirements, ensuring that analytical data withstands scrutiny throughout the regulatory review process.
Looking Ahead
As pharmaceutical development continues to evolve with new modalities including cell therapies, gene therapies, and complex biologics, the demand for advanced particle characterisation will only grow. Malvern Panalytical remains committed to developing innovative measurement solutions that enable pharmaceutical scientists to push the boundaries of drug development and ultimately deliver better treatments to patients worldwide.